In Vitro and In Vivo Evaluations of β-Lactam/β-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan

Increasing carbapenem resistance rates worldwide underscored the urgent need of novel antimicrobials. Ceftazidime–avibactam and aztreonam–avibactam combinations are developed to combat carbapenem resistance, but biological and geographic variations must be considered for antibiotic susceptibility pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tsung-Ying, Hsieh, Ya-Ju, Kao, Li-Ting, Liu, Guan-Hong, Lian, Shao-Hsuan, Wang, Liang-Chun, Lin, I-Ling, Lin, Yu-Tzu, Wang, Sheng-Fan, Tseng, Sung-Pin, Lu, Po-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764198/
https://www.ncbi.nlm.nih.gov/pubmed/33322803
http://dx.doi.org/10.3390/microorganisms8121981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764198/
https://www.ncbi.nlm.nih.gov/pubmed/33322803
http://dx.doi.org/10.3390/microorganisms8121981

Ejemplares similares